Skip to main content
logo
IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
81.11
+1.69 (2.13%)
At close: Nov 3, 2026, 4:00 PM EST
81.11
0.00 (0.00%)
After-hours: Nov 3, 2026, 4:10 PM EST

IRADIMED CORPORATION Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
23.9822.4819.2317.1912.839.33
Depreciation & Amortization
1.661.170.820.770.671.41
Loss (Gain) From Sale of Assets
0.010.0400.01-00.01
Loss (Gain) From Sale of Investments
-----0.01-0.02
Stock-Based Compensation
2.962.922.522.191.391.46
Provision & Write-off of Bad Debts
0.09-0.08-0.10.210.10.01
Other Operating Activities
1.992.77-0.61-0.990.110.64
Change in Accounts Receivable
0.09-3.031.760.84-8.24-0.58
Change in Inventory
-2.29-1.383.13-7.47-1.31-0.39
Change in Accounts Payable
0.09-0.08-0.86-0.221.120.03
Change in Unearned Revenue
1.131.6-0.110.620.530.05
Change in Income Taxes
-2.2-0.76-0.790.253.05-0.83
Change in Other Net Operating Assets
-0.37-0.70.620.06-0.210.14
Operating Cash Flow
27.1524.9525.6213.4710.0411.26
Operating Cash Flow Growth
8.55%-2.64%90.30%34.08%-10.80%93.52%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.01-7.77-8.01-7.44-0.82-0.48
Sale (Purchase) of Intangibles
-0.53-0.66-0.81-0.57-1.05-0.26
Investment in Securities
----0.51.39
Investing Cash Flow
-1.54-8.42-8.82-8.01-1.370.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--0.030.180.150.62
Repurchase of Common Stock
-2.62-2.56-0.69-0.61-0.29-0.6
Common Dividends Paid
-16.23-15.04-13.68-13.22-12.56-
Financing Cash Flow
-18.85-17.6-14.34-13.66-12.710.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
--0---
Net Cash Flow
6.76-1.082.47-8.2-4.0411.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
26.1417.1817.626.029.2210.78
Free Cash Flow Growth
77.19%-2.48%192.46%-34.66%-14.44%100.50%
Free Cash Flow Margin
29.26%20.50%24.06%9.19%17.30%25.77%
Free Cash Flow Per Share
2.031.341.380.470.730.86
Levered Free Cash Flow
17.536.644.18.45.898.16
Unlevered Free Cash Flow
17.536.644.18.45.898.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
7.443.926.515.351.710.97
Change in Working Capital
-3.55-4.353.75-5.91-5.06-1.58
SEC Filings: 10-K · 10-Q